Angibaud Patrick Rene
Janssen Pharmaceutica
33 Papers
425 Citations
Angibaud Patrick Rene is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Histone deacetylase & Derivative (chemistry). The author has an hindex of 12, co-authored 33 publications. Previous affiliations of Angibaud Patrick Rene include Janssen-Cilag & Astex.
Chat about Author
Papers
Patent
Farnesyl transferase inhibiting 2-quinolone derivatives
David William End,Venet Marc Gaston,Angibaud Patrick Rene,Sanz Gerard Charles +3 more
- 25 Oct 1996
TL;DR: In this paper, the authors describe the stereoisomeric forms of compounds of formula (I) and the pharmaceutically acceptable acid or base addition salts thereof, wherein the dotted line represents an optional bond.
83
Patent
New inhibitors of histone deacetylase
Angibaud Patrick Rene,Isabelle Noëlle Constance Pilatte,Brandt Sven Franciscus Anna Va,Bruno Roux,Holte Peter Ten,Verdonck Marc Gustaaf Celine,Lieven Meerpoel,Alexey B. Dyatkin +7 more
- 11 Mar 2003
TL;DR: In this paper, the novel compounds of formula (I) have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
78
Patent
Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
Berdini Valerio,Gordon Saxty,Christopher William Murray,Besong Gilbert Ebai,Christopher Charles Frederick Hamlett,Steven John Woodhead,Ligny Yannick Aimé Eddy,Angibaud Patrick Rene +7 more
- 29 Nov 2011
TL;DR: In this article, the authors proposed new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, processes for the preparation of said compounds and to the use of such compounds in the treatment of diseases, e.g. cancer.
32
Patent
Quinolinone derivatives as parp and tank inhibitors
Jorge Vialard,Angibaud Patrick Rene,Laurence Anne Mevellec,Christophe Meyer,Eddy Jean Edgard Freyne,Isabelle Noëlle Constance Pilatte,Bruno Roux,Elisabeth Thérèse Jeanne Pasquier,Bourdrez Xavier Marc,Adelinet Christophe Denis,Laurence Françoise Bernadette Marconnet-Decrane,Jacqueline Macritchie,James Duffy,Andrew Pate Owens,Pierre-Henri Storck,Poncelet Virginie Sophie +15 more
- 07 Mar 2008
TL;DR: In this paper, the present invention provides compounds of Formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds, wherein R1, R2, R3, R4, R5, R6, R7, n, m and X have defined meanings.
24
Patent
Quinolines as fgfr kinase modulators
Berdini Valerio,Angibaud Patrick Rene,Steven John Woodhead,Gordon Saxty +3 more
- 26 Oct 2012
TL;DR: In this paper, the authors introduced new quinoline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of such compounds in the treatment of diseases, e.g. cancer.
21